Calidi Biotherapeutics Inc. (CLDI): Price Chart

Calidi Biotherapeutics (CLDI) laboratory capacities are currently utilized for the production of clinical trial drugs and cell culture system services. The brand is enhancing its status as a leading virotherapy center by implementing stem cell protection for anti-cancer viruses. The stock price history reflects the dynamics of an asset whose revenue relies on insurance reimbursements for tumor therapy, with the current indicator standing at 0.67.

CLDI - Calidi Biotherapeutics Share Price over the range 02/21/2024 - 11/11/2026

Metric breakdowns and analytics for Calidi Bio (CLDI)

- stock quotes and analyst forecast:

Stock Price Calidi Biotherapeutics|CLDI - Consensus Target

- stock exchange capitalization data:

Market Value Calidi Biotherapeutics Inc.|CLDI - Total Company Value

- balance sheet equity data:

Book Value per Share Calidi Biotherapeutics|CLDI - Accounting Capitalization|Market Capitalization to Book Value Ratio calidibio.com|CLDI - Company Total Asset Base

- debt obligations and liquidity statistics:

Total Debt to Capital Calidi Biotherapeutics|CLDI - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Calidi Biotherapeutics|CLDI - Company Aggregate Debts|Debt to Book Capitalization Ratio Calidi Biotherapeutics Inc.|CLDI - Company Long-Term Indebtedness|Company Short-Term Debts Calidi Biotherapeutics|Quick Ratio calidibio.com

- earnings and market ratios statistics:

CLDI - Company Net Income|Expected Profit Calidi Biotherapeutics|CLDI - Company Value to Net Income|Projected Price to Earnings Calidi Biotherapeutics|CLDI - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Calidi Biotherapeutics Inc.|CLDI - Operating profit before deduction of amortization|Net earnings per share for the last 12 months Calidi Biotherapeutics|CLDI - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months calidibio.com|CLDI - Earnings per share increase in current year|Earnings growth forecast for next year Calidi Biotherapeutics

Comprehensive company analysis:CLDI Calidi Biotherapeutics, Inc.

Market expectations for Calidi Biotherapeutics (CLDI) depend on the successful application of stem cells for the delivery of oncolytic viruses in the fight against tumors. This price chart reflects the current market capitalization through the amount investors are willing to pay per share, characterizing the speculative asset class within the biopharmaceutical sector.

Who Calidi Biotherapeutics competes with